statistiche ricercatore

Continente	#
EU - Europa	690
NA - Nord America	685
AS - Asia	346
SA - Sud America	53
AF - Africa	8
Continente sconosciuto - Info sul continente non disponibili	1
Totale	1.783

Nazione	#
US - Stati Uniti d'America	665
IT - Italia	308
CN - Cina	111
SG - Singapore	107
GB - Regno Unito	71
RU - Federazione Russa	69
DE - Germania	56
VN - Vietnam	44
FI - Finlandia	38
BR - Brasile	35
UA - Ucraina	31
SE - Svezia	29
FR - Francia	24
IN - India	21
TR - Turchia	18
IE - Irlanda	17
CA - Canada	11
AR - Argentina	10
PL - Polonia	9
MX - Messico	8
HK - Hong Kong	6
KR - Corea	6
PH - Filippine	6
PK - Pakistan	6
BD - Bangladesh	5
ES - Italia	5
JP - Giappone	5
LT - Lituania	5
AT - Austria	4
NL - Olanda	4
BE - Belgio	3
CH - Svizzera	3
MA - Marocco	3
PE - Perù	3
CO - Colombia	2
DK - Danimarca	2
EC - Ecuador	2
HU - Ungheria	2
ID - Indonesia	2
IL - Israele	2
IR - Iran	2
PT - Portogallo	2
RS - Serbia	2
TW - Taiwan	2
ZA - Sudafrica	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
CZ - Repubblica Ceca	1
EU - Europa	1
GH - Ghana	1
HR - Croazia	1
JM - Giamaica	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
MK - Macedonia	1
RO - Romania	1
SI - Slovenia	1
TG - Togo	1
TN - Tunisia	1
VE - Venezuela	1
Totale	1.783

Nome	#
Sviluppo ed umanizzazione di un anticorpo in formato scFv contro β-1,3 glucano	279
Humanization of Antibodies using a Statistical Inference Approach	224
I-152, a supplier of N-acetyl-cysteine and cysteamine, inhibits immunoglobulin secretion and plasma cell maturation in LP-BM5 murine leukemia retrovirus-infected mice by affecting the unfolded protein response	220
The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses?	185
A new humanized antibody is effective against pathogenic fungi in vitro	165
A biotechnological approach for the production of new protein bioplastics	157
Intracellular Redox-Modulated Pathways as Targets for Effective Approaches in the Treatment of Viral Infection	131
A biotechnological approach for the production of new protein bioplastics	124
Development and in vitro characterization of a humanized scFv against fungal infections	116
AFM evaluation of a humanized recombinant antibody affecting C. auris cell wall and stability	83
CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort Study	67
Development and characterization of DIA 12.3, a fully human intact anti-CEACAM1 monoclonal antibody	65
Totale	1.816

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	125	0	0	0	0	0	5	12	11	16	26	7	48
2021/2022	137	19	8	11	18	5	11	2	17	7	5	15	19
2022/2023	143	11	5	9	11	8	23	0	20	27	11	9	9
2023/2024	89	9	1	2	20	9	13	4	7	0	9	2	13
2024/2025	513	15	9	93	40	22	26	87	41	40	38	64	38
2025/2026	430	84	57	83	121	76	9	0	0	0	0	0	0
Totale													1.816